News

  • 1 November 2011

    Pfizer acquires Icagen

    Pfizer, through its wholly owned subsidiary Eclipse Acquisition, has completed the acquisition of biopharmaceutical company Icagen.

  • 1 November 2011

    FDA clears Vegenics VGX-100 drug trial

    The US Food and Drug Administration (FDA) has approved an investigational new drug application from Vegenics, a subsidiary of Circadian Technologies, to commence clinical trials of VGX-100 for the treatment...

  • 31 October 2011

    FDA approves Mylan pain drug

    Mylan's abbreviated new drug application for morphine sulphate extended-release tablets has been approved by the US Food and Drug Administration (FDA) .

  • 30 October 2011

    Biotie and Merck turn their backs on Newron

    Finland’s Biotie Therapies has pulled out of its planned merger with Newron Pharmaceuticals following a decision by Merck to return the full global rights to investigational Parkinson's disease drug safinamide...

  • 30 October 2011

    Bristol-Myers Squibb reports strong revenue rise

    Bristol-Myers Squibb (BMS) has reported strong third quarter results, announcing an 11% increase in revenue to $5.35bn attributed to the company’s blood thinning drug Plavix.

Close
Close
Close

Go Top